PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28302487-7	2017	Here, we observed lncRNA TUG1 was associated to the MTX resistant in colorectal cancer cells.	Methotrexate	52-55	taurine up-regulated 1	Homo sapiens	25-29	
28302487-8	2017	Firstly, quantitative analysis indicated that TUG1 was significantly increased in tumors which were resistant to MTX treatment.	Methotrexate	113-116	taurine up-regulated 1	Homo sapiens	46-50	
28302487-9	2017	TUG1 knockdown re-sensitized the MTX resistance in colorectal cancer cells, which were MTX-resistant colorectal cell line.	Methotrexate	33-36	taurine up-regulated 1	Homo sapiens	0-4	
28302487-9	2017	TUG1 knockdown re-sensitized the MTX resistance in colorectal cancer cells, which were MTX-resistant colorectal cell line.	Methotrexate	87-90	taurine up-regulated 1	Homo sapiens	0-4	
28302487-12	2017	Taken together, our study suggests that lncRNA TUG1 mediates MTX resistance in colorectal cancer via miR-186/CPEB2 axis.	Methotrexate	61-64	taurine up-regulated 1	Homo sapiens	47-51	
28302487-0	2017	TUG1 mediates methotrexate resistance in colorectal cancer via miR-186/CPEB2 axis.	Methotrexate	14-26	taurine up-regulated 1	Homo sapiens	0-4